✦ LIBER ✦

Phase II trial of VP-16-213 in advanced ovarian carcinoma

✍ Scribed by Brian L. Hillcoat; J.J. Campbell; Roger Pepperell; Michael A. Quinn; James F. Bishop; Arthur Day

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical trial of VP-16-213 (et

✍ Flemming Hansen; Inger Malthe; Hans Krog 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Cisplatin plus VP16-213 in advanced ovar

✍ P.R. Harnett; D.R. Bell; B.L. Hillcoat; R.L. Woods; J.A. Levi; R.M. Rome; J.C. C 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Phase II study of oral VP-16-213 in hepa

✍ Cavalli, F.; Rozencweig, M.; Renard, J.; Goldhirsch, A.; Hansen, H.H. 📂 Article 📅 1981 🏛 Elsevier Science ⚖ 333 KB

Phase II evaluation of VP-16-213 (NSC-14

✍ J.H. Edmonson; D.G. Decker; G.D. Malkasian; M.J. Webb; E.O. Jorgensen 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Phase II trial of VP16–213 in squamous c

✍ Clerico, Mario; Bertetto, Oscar; Dongiovanni, Vincenzo; Calciati, Alessandro 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 92 KB

Phase II study of VP16-213 (Etoposide) i

✍ F. C. Schell; H. Y. Yap; G. N. Hortobagyi; B. Issell; L. Esparza 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 302 KB